Humacyte Inc. Common Stock (NASDAQ: HUMA)
27 Days left to seek lead plaintiff status.
On November 18, 2024, Humacyte, Inc. was sued for violations of the federal securities laws in the United States District Court for the Middle District of North Carolina on behalf of investors who purchased or otherwise acquired Humacyte securities between May 10, 2024 and October 17, 2024, inclusive (the “Class Period”).